Clinical Trial Results
Dr. C. Michael Gibson Presents: Secondary Prevention with Aspirin – Learn about the Latest FDA Approved Aspirin Formulation View
Disclosures: Consultant to PLx Pharma Inc.
Aspirin Therapy in 2022: New Horizons
A CME-Jointly Accredited Program This activity is supported by an independent educational grant from PLx Pharma Inc.
Aspirin in 2022: A New Aspirin for a New Chapter
Dr. Neha J. Pagidipati, Dr. Jacqueline E. Tamis-Holland, Dr. Dominick J. Angiolillo and Dr. C. Michael Gibson Discuss: Aspirin in […]